HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

Abstract
We investigated the possibility of using a pharmacologic agent to modulate viral gene expression to target radiotherapy to tumor tissue. In a mouse xenograft model, we had previously shown targeting of [(125)I]2'-fluoro-2'-deoxy-beta-D-5-iodouracil-arabinofuranoside ([(125)I]FIAU) to tumors engineered to express the Epstein-Barr virus thymidine kinase (EBV-TK). Here we extend those results to targeting of a therapeutic radiopharmaceutical [(131)I]FIAU to slow or stop tumor growth or to achieve tumor regression. These outcomes were achieved in xenografts with tumors that constitutively expressed the EBV-TK. With naturally infected EBV tumor cell lines (Burkitt's lymphoma and gastric carcinoma), activation of viral gene expression by pretreatment with bortezomib was required. Marked changes in tumor growth could also be achieved in naturally infected Kaposi's sarcoma herpesvirus tumors after pretreatment with bortezomib. Bortezomib-induced enzyme-targeted radiation therapy illustrates the possibility of pharmacologically modulating tumor gene expression to result in targeted radiotherapy.
AuthorsDe-Xue Fu, Yvette Tanhehco, Jianmeng Chen, Catherine A Foss, James J Fox, Ja-Mun Chong, Robert F Hobbs, Masashi Fukayama, George Sgouros, Jeanne Kowalski, Martin G Pomper, Richard F Ambinder
JournalNature medicine (Nat Med) Vol. 14 Issue 10 Pg. 1118-22 (Oct 2008) ISSN: 1546-170X [Electronic] United States
PMID18776891 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antineoplastic Agents
  • Boronic Acids
  • Iodine Radioisotopes
  • Pyrazines
  • Radiopharmaceuticals
  • Arabinofuranosyluracil
  • fialuridine
  • Bortezomib
  • Thymidine Kinase
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Arabinofuranosyluracil (analogs & derivatives, therapeutic use)
  • Boronic Acids (pharmacology)
  • Bortezomib
  • Burkitt Lymphoma (radiotherapy)
  • Cell Line, Tumor
  • Herpesviridae Infections (radiotherapy)
  • Herpesvirus 4, Human (enzymology)
  • Humans
  • Iodine Radioisotopes (therapeutic use)
  • Male
  • Mice
  • Mice, SCID
  • Pyrazines (pharmacology)
  • Radiopharmaceuticals (therapeutic use)
  • Sarcoma, Kaposi (radiotherapy)
  • Stomach Neoplasms (radiotherapy)
  • Thymidine Kinase (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: